Travere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease
The FDA approved Filspari to reduce proteinuria in some patients with focal segmental glomerulosclerosis. The agency approved the…
Three Stocks Estimated To Be Undervalued In July 2025
Over the past year, the United States market has experienced a 13% increase despite remaining flat over the…